Eleison Pharmaceuticals to Partner with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, to Develop and Commercialize Glufosfamide for the China Market

Shenogen Pharma and Lee’s Pharm entered into a Collaboration Agreement for a Combination Product for Treatment of Late Stage Cancers

Windtree and Lee’s Pharm Close $10 Million Share Purchase Agreement Giving Lee’s Pharm Controlling Interest in Windtree

Appointment Of Ms. Zhang Zhen Hua, Ada As Group Director Of Human Resources And Development Of Lee’s Pharmaceutical Holdings Limited

Zingo® for Needle-free Local Analgesia is approved by Hong Kong Department of Health

SillaJen and Lee’s Pharmaceutical Announce Approval by the China CFDA to Commence Phase 3 Clinical Trial for Oncolytic Immunotherapy, Pexa-Vec, in Liver Cancer

Adapalene and Clindamycin combination hydrochloride Gel meets pre-specified endpoints in Phase Ib-IIa clinical study in Acne Vulgaris (Moderate to severe acne)